Item 8.01 – Other Information.
On June 8, 2021, Sesen Bio, Inc. (the “Company”) announced that at the conclusion of the 2021 Russell indexes annual reconstitution, the Company is expected to be included in the Russell 3000® Index effective after the US market opens on June 28, 2021, according to a preliminary list of additions.
In connection with inclusion on the Russell 3000® Index, the Company anticipates leading indexes that follow Russell indexes to purchase shares of the Company’s common stock prior to June 28th, potentially expanding the Company’s exposure to a broader investment community.
Membership in the US all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $10.6 trillion in assets are benchmarked against Russell’s US indexes. Russell indexes are part of FTSE Russell, a leading global index provider.
More information on the Russell 3000® Index and the Russell indexes reconstitution is available at the “Russell Reconstitution” section on the FTSE Russell website.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:
This Current Report on Form 8-K contains forward-looking statements, including, but not limited to, the Company’s expectation that it will be included in the Russell 3000® Index and its anticipation that trading in the Company’s common stock will occur as a result of such inclusion. These forward-looking statements are based on the Company’s current expectations and inherently involve significant risks and uncertainties. The Company’s actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties. A further description of the risks and uncertainties relating to the business of the Company is contained in the Company’s most recent annual report on Form 10-K and the Company’s quarterly reports on Form 10-Q, as well as any amendments thereto reflected in subsequent filings with the SEC. The Company undertakes no duty or obligation to update any forward-looking statements contained in this report as a result of new information, future events or changes in its expectations.